TY - JOUR
T1 - Assessing the diagnostic accuracy of PCR-based detection of Streptococcus pneumoniae from nasopharyngeal swabs collected for viral studies in Canadian adults hospitalised with community-acquired pneumonia
T2 - A Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research (CIRN) study
AU - Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research (CIRN)
AU - Gillis, Hayley D.
AU - Lang, Amanda L.S.
AU - Elsherif, May
AU - Martin, Irene
AU - Hatchette, Todd F.
AU - McNeil, Shelly A.
AU - LeBlanc, Jason J.
AU - Andrew, Melissa
AU - Webster, Duncan
AU - Trottier, Sylvie
AU - Boivin, Guy
AU - Valiquette, Louis
AU - Semret, Makeda
AU - McCarthy, Anne
AU - McGeer, Allison
AU - Loeb, Mark
AU - Johnstone, Jennie
AU - Bowie, William
AU - Stiver, Grant
N1 - Funding Information:
This work was supported by the Public Health Agency of Canada (PHAC), the Canadian Institutes of Health Research (CIHR) (grant number 23338) and by an investigator-initiated research grant to SAMN and the Canadian Immunization Research Network (CIRN) from Pfizer Canada (grant number PF1001). No study sponsors were involved in the study design, specimen collection, analysis and interpretation of data, scientific writing or decision to submit the paper for publication.
Publisher Copyright:
© 2017 Article author(s).
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Study design: Detection and serotyping of Streptococcus pneumoniae are important to assess the impact of pneumococcal vaccines. This study describes the diagnostic accuracy of PCR-based detection of S. pneumoniae directly from nasopharyngeal (NP) swabs collected for respiratory virus studies. Methods: Active surveillance for community-acquired pneumonia (CAP) in hospitalised adults was performed from December 2010 to 2013. Detection of pneumococcal CAP (CAPSpn) was performed by urine antigen detection (UAD), identification of S. pneumoniae in sputum or blood cultures. S. pneumoniae was detected in NP swabs using lytA and cpsA real-time PCR, and serotyping was performed using conventional and real-time multiplex PCRs. For serotyping, the Quellung reaction, PCR-based serotyping or a serotype-specific UAD was used. Results: NP swab results were compared against CAP cases where all pneumococcal tests were performed (n=434), or where at least one test was performed (n=1616). CAPSpn was identified in 22.1% (96/434) and 14.9% (240/1616), respectively. The sensitivity of NP swab PCR for the detection of S. pneumoniae was poor for CAPSpn (35.4% (34/96) and 34.17% (82/240)), but high specificity was observed (99.4% (336/338) and 97.89% (1347/1376)). Of the positive NP swabs, a serotype could be deduced by PCR in 88.2% (30/34) and 93.9% (77/82), respectively. Conclusions: While further optimisation may be needed to increase the sensitivity of PCR-based detection, its high specificity suggests there is a value for pneumococcal surveillance. With many laboratories archiving specimens for influenza virus surveillance, this specimen type could provide a non-culture-based method for pneumococcal surveillance.
AB - Study design: Detection and serotyping of Streptococcus pneumoniae are important to assess the impact of pneumococcal vaccines. This study describes the diagnostic accuracy of PCR-based detection of S. pneumoniae directly from nasopharyngeal (NP) swabs collected for respiratory virus studies. Methods: Active surveillance for community-acquired pneumonia (CAP) in hospitalised adults was performed from December 2010 to 2013. Detection of pneumococcal CAP (CAPSpn) was performed by urine antigen detection (UAD), identification of S. pneumoniae in sputum or blood cultures. S. pneumoniae was detected in NP swabs using lytA and cpsA real-time PCR, and serotyping was performed using conventional and real-time multiplex PCRs. For serotyping, the Quellung reaction, PCR-based serotyping or a serotype-specific UAD was used. Results: NP swab results were compared against CAP cases where all pneumococcal tests were performed (n=434), or where at least one test was performed (n=1616). CAPSpn was identified in 22.1% (96/434) and 14.9% (240/1616), respectively. The sensitivity of NP swab PCR for the detection of S. pneumoniae was poor for CAPSpn (35.4% (34/96) and 34.17% (82/240)), but high specificity was observed (99.4% (336/338) and 97.89% (1347/1376)). Of the positive NP swabs, a serotype could be deduced by PCR in 88.2% (30/34) and 93.9% (77/82), respectively. Conclusions: While further optimisation may be needed to increase the sensitivity of PCR-based detection, its high specificity suggests there is a value for pneumococcal surveillance. With many laboratories archiving specimens for influenza virus surveillance, this specimen type could provide a non-culture-based method for pneumococcal surveillance.
UR - http://www.scopus.com/inward/record.url?scp=85020639335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020639335&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2016-015008
DO - 10.1136/bmjopen-2016-015008
M3 - Article
C2 - 28600368
AN - SCOPUS:85020639335
SN - 2044-6055
VL - 7
JO - BMJ Open
JF - BMJ Open
IS - 6
M1 - e015008
ER -